Literature DB >> 33665167

Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management.

Jianyao Lou1, Yunxiang Zhou2, Zengyu Feng3, Mindi Ma4, Yihan Yao2, Yali Wang2, Yongchuan Deng2, Yulian Wu1.   

Abstract

Regulated necrosis is an emerging type of cell death independent of caspase. Recently, with increasing findings of regulated necrosis in the field of biochemistry and genetics, the underlying molecular mechanisms and signaling pathways of regulated necrosis are gradually understood. Nowadays, there are several modes of regulated necrosis that are tightly related to cancer initiation and development, including necroptosis, ferroptosis, parthanatos, pyroptosis, and so on. What's more, accumulating evidence shows that various compounds can exhibit the anti-cancer effect via inducing regulated necrosis in cancer cells, which indicates that caspase-independent regulated necrosis pathways are potential targets in cancer management. In this review, we expand the molecular mechanisms as well as signaling pathways of multiple modes of regulated necrosis. We also elaborate on the roles they play in tumorigenesis and discuss how each of the regulated necrosis pathways could be therapeutically targeted.
Copyright © 2021 Lou, Zhou, Feng, Ma, Yao, Wang, Deng and Wu.

Entities:  

Keywords:  cancer therapy; ferroptosis; necroptosis; parthanatos; pyroptosis; regulated necrosis

Year:  2021        PMID: 33665167      PMCID: PMC7921719          DOI: 10.3389/fonc.2020.616952

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  260 in total

1.  Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine.

Authors:  Congying Chen; Wenqin Xiao; Li Huang; Ge Yu; Jianbo Ni; Lijuan Yang; Rong Wan; Guoyong Hu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Recent Progress in Ferroptosis Inducers for Cancer Therapy.

Authors:  Chen Liang; Xinglin Zhang; Mengsu Yang; Xiaochen Dong
Journal:  Adv Mater       Date:  2019-10-08       Impact factor: 30.849

3.  Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly.

Authors:  Kaiwen W Chen; Benjamin Demarco; Rosalie Heilig; Kateryna Shkarina; Andreas Boettcher; Christopher J Farady; Pawel Pelczar; Petr Broz
Journal:  EMBO J       Date:  2019-03-22       Impact factor: 11.598

Review 4.  Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer.

Authors:  Fanghua Qi; Anyuan Li; Yoshinori Inagaki; Jianjun Gao; Jijun Li; Norihiro Kokudo; Xiao-Kang Li; Wei Tang
Journal:  Biosci Trends       Date:  2010-12       Impact factor: 2.400

Review 5.  Viral modulation of programmed necrosis.

Authors:  William J Kaiser; Jason W Upton; Edward S Mocarski
Journal:  Curr Opin Virol       Date:  2013-06-15       Impact factor: 7.090

Review 6.  PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

Authors:  Andreína Peralta-Leal; José Manuel Rodríguez-Vargas; Rocío Aguilar-Quesada; María Isabel Rodríguez; José Luis Linares; Mariano Ruiz de Almodóvar; F Javier Oliver
Journal:  Free Radic Biol Med       Date:  2009-04-10       Impact factor: 7.376

7.  Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.

Authors:  Indira Jutooru; Aaron S Guthrie; Gayathri Chadalapaka; Satya Pathi; KyoungHyun Kim; Robert Burghardt; Un-Ho Jin; Stephen Safe
Journal:  Mol Cell Biol       Date:  2014-04-14       Impact factor: 4.272

8.  The Lived Experiences of Adolescents With Cancer: A Phenomenological Study.

Authors:  Ching-Hui Chien; Yung-Ying Chang; Xuan-Yi Huang
Journal:  Clin Nurs Res       Date:  2018-09-06       Impact factor: 2.075

9.  Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment.

Authors:  Jian Hu; Yi Dong; Li Ding; Yang Dong; Zhihua Wu; Wenping Wang; Ming Shen; Yourong Duan
Journal:  Signal Transduct Target Ther       Date:  2019-09-06

10.  Key roles of necroptotic factors in promoting tumor growth.

Authors:  Xinjian Liu; Min Zhou; Ling Mei; Jiaying Ruan; Qian Hu; Jing Peng; Hang Su; Hong Liao; Shanling Liu; WeiPing Liu; He Wang; Qian Huang; Fang Li; Chuan-Yuan Li
Journal:  Oncotarget       Date:  2016-04-19
View more
  5 in total

Review 1.  The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era.

Authors:  Eunjin Ju; Kyeong Ah Park; Han-Ming Shen; Gang Min Hur
Journal:  Exp Mol Med       Date:  2022-09-28       Impact factor: 12.153

2.  Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.

Authors:  R Singh; U P Singh; V Agrawal; M Garg
Journal:  Mol Biol Rep       Date:  2022-05-20       Impact factor: 2.742

3.  Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis.

Authors:  Hongkun Cai; Feng Guo; Shuang Wen; Xin Jin; Heshui Wu; Dianyun Ren
Journal:  J Exp Clin Cancer Res       Date:  2022-02-22

Review 4.  A Mini Review on Molecules Inducing Caspase-Independent Cell Death: A New Route to Cancer Therapy.

Authors:  Kakali Bhadra
Journal:  Molecules       Date:  2022-09-28       Impact factor: 4.927

5.  Caspase-Independent programmed cell death is not necessarily necroptosis.

Authors:  Yujie Lin; Hongyao Li; Jian Li; Hao Gu; Peiwu Li
Journal:  JTCVS Open       Date:  2022-04-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.